Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

  • Technology appraisal guidance
  • TA225
  • Published: 
Download (PDF)

Sources of advice and support

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-84936-626-7

  • Information Standard